Transactions 26
| X |
Filed |
Traded |
Ticker |
Company |
Insider |
Title |
Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
|
2026-07-02 16:04 |
2026-07-01 |
CCCC |
C4 Therapeutics, Inc. |
Anderson Kenneth Carl |
Dir |
A - Grant |
$4.34 |
+2,650 |
72.0K |
+4% |
+$11.5K |
| D |
2026-06-04 16:14 |
2026-06-01 |
CCCC |
C4 Therapeutics, Inc. |
Anderson Kenneth Carl |
Dir |
M - OptEx |
$2.11 |
+1,070 |
69.3K |
+2% |
+$2,258 |
|
2026-04-03 10:45 |
2026-04-01 |
CCCC |
C4 Therapeutics, Inc. |
Anderson Kenneth Carl |
Dir |
A - Grant |
$2.70 |
+4,259 |
68.2K |
+7% |
+$11.5K |
|
2026-01-05 |
2026-01-02 |
CCCC |
C4 Therapeutics, Inc. |
Anderson Kenneth Carl |
Dir |
A - Grant |
$1.93 |
+5,958 |
146.5K |
+4% |
+$11.5K |
|
2025-10-03 |
2025-10-01 |
CCCC |
C4 Therapeutics, Inc. |
Anderson Kenneth Carl |
Dir |
A - Grant |
$2.15 |
+5,349 |
140.6K |
+4% |
+$11.5K |
|
2025-07-02 |
2025-07-01 |
CCCC |
C4 Therapeutics, Inc. |
Anderson Kenneth Carl |
Dir |
A - Grant |
$1.51 |
+7,616 |
135.2K |
+6% |
+$11.5K |
|
2025-04-03 |
2025-04-01 |
CCCC |
C4 Therapeutics, Inc. |
Anderson Kenneth Carl |
Dir |
A - Grant |
$1.44 |
+7,841 |
127.6K |
+7% |
+$11.3K |
|
2025-01-03 |
2025-01-02 |
CCCC |
C4 Therapeutics, Inc. |
Anderson Kenneth Carl |
Dir |
A - Grant |
$3.66 |
+3,074 |
119.8K |
+3% |
+$11.3K |
|
2024-10-02 |
2024-10-01 |
CCCC |
C4 Therapeutics, Inc. |
Anderson Kenneth Carl |
Dir |
A - Grant |
$5.56 |
+2,023 |
116.7K |
+2% |
+$11.2K |
|
2024-07-02 |
2024-07-01 |
CCCC |
C4 Therapeutics, Inc. |
Anderson Kenneth Carl |
Dir |
A - Grant |
$4.85 |
+2,320 |
114.7K |
+2% |
+$11.3K |
|
2024-04-02 |
2024-04-01 |
CCCC |
C4 Therapeutics, Inc. |
Anderson Kenneth Carl |
Dir |
A - Grant |
$8.10 |
+1,389 |
112.4K |
+1% |
+$11.3K |
|
2024-01-03 |
2024-01-02 |
CCCC |
C4 Therapeutics, Inc. |
Anderson Kenneth Carl |
Dir |
A - Grant |
$6.52 |
+1,725 |
111.0K |
+2% |
+$11.2K |
|
2023-10-03 |
2023-10-02 |
CCCC |
C4 Therapeutics, Inc. |
Anderson Kenneth Carl |
Dir |
A - Grant |
$1.70 |
+6,617 |
109.2K |
+6% |
+$11.2K |
|
2023-07-05 |
2023-07-03 |
CCCC |
C4 Therapeutics, Inc. |
Anderson Kenneth Carl |
Dir |
A - Grant |
$2.83 |
+3,976 |
102.6K |
+4% |
+$11.3K |
|
2023-04-04 |
2023-04-03 |
CCCC |
C4 Therapeutics, Inc. |
Anderson Kenneth Carl |
Dir |
A - Grant |
$3.20 |
+3,516 |
98.6K |
+4% |
+$11.3K |
| DM |
2023-01-06 |
2023-01-06 |
CCCC |
C4 Therapeutics, Inc. |
Anderson Kenneth Carl |
Dir |
M - OptEx |
$3.90 |
+712 |
95.1K |
+0.8% |
+$2,777 |
|
2023-01-04 |
2023-01-03 |
CCCC |
C4 Therapeutics, Inc. |
Anderson Kenneth Carl |
Dir |
A - Grant |
$6.38 |
+1,568 |
94.4K |
+2% |
+$10.0K |
| D |
2022-10-04 |
2022-10-03 |
CCCC |
C4 Therapeutics, Inc. |
Anderson Kenneth Carl |
Dir |
A - Grant |
$8.69 |
+1,150 |
92.8K |
+1% |
+$9,994 |
| DM |
2022-10-04 |
2022-10-03 |
CCCC |
C4 Therapeutics, Inc. |
Anderson Kenneth Carl |
Dir |
M - OptEx |
$3.90 |
+712 |
91.3K |
+0.8% |
+$2,779 |
| DM |
2022-07-18 |
2022-07-15 |
CCCC |
C4 Therapeutics, Inc. |
Anderson Kenneth Carl |
Dir |
M - OptEx |
$3.90 |
+1,424 |
91.0K |
+2% |
+$5,556 |
|
2022-07-05 |
2022-07-01 |
CCCC |
C4 Therapeutics, Inc. |
Anderson Kenneth Carl |
Dir |
A - Grant |
$8.03 |
+1,246 |
89.6K |
+1% |
+$10.0K |
|
2022-04-05 |
2022-04-04 |
CCCC |
C4 Therapeutics, Inc. |
Anderson Kenneth Carl |
Dir |
A - Grant |
$26.46 |
+341 |
88.3K |
+0.4% |
+$9,023 |
| DM |
2022-01-26 |
2022-01-26 |
CCCC |
C4 Therapeutics, Inc. |
Anderson Kenneth Carl |
Dir |
M - OptEx |
$3.90 |
+2,137 |
88.0K |
+2% |
+$8,338 |
|
2022-01-18 |
2022-01-04 |
CCCC |
C4 Therapeutics, Inc. |
Anderson Kenneth Carl |
Dir |
A - Grant |
$31.58 |
+278 |
85.8K |
+0.3% |
+$8,779 |
|
2021-10-05 |
2021-10-04 |
CCCC |
C4 Therapeutics, Inc. |
Anderson Kenneth Carl |
Dir |
A - Grant |
$44.99 |
+194 |
85.6K |
+0.2% |
+$8,728 |
|
2021-07-07 |
2021-07-02 |
CCCC |
C4 Therapeutics, Inc. |
Anderson Kenneth Carl |
Dir |
A - Grant |
$39.72 |
+220 |
85.4K |
+0.3% |
+$8,738 |
Purchase
Sale
Sale after option exercise
All abbreviations